Making Regulated Software as a Medical Device(SaMD) Simpler/ Faster/ Engaging

At Wellthy Therapeutics, we enable life science companies to deliver and scale regulatory compliant, Software as a Medical Device (SaMD) based digital health solutions to amplify real-world evidence for life science products.

Building Clinically Validated Digital Therapeutic Solutions for Leading Life Sciences

pfizer-logo
roche

Revolutionizing Value based care across complex conditions and rare diseases

Type-2-Diabetes
Dyslipidemia
Congestive
Kidney-Disease
Asthma

Helping You Build SaMD Solutions
the Right way

Hi There! At Wellthy Therapeutics, we provide you with a globally regulated and compliant DTx platform to build clinically validated DTx solutions and help you scale your SaMD Solutions across geographies, drug therapies, and languages. Not only can we build for you but also provide expert guidance on SaMD development from discovery to commercialization.

Explore Wellthy CARE™ Platform

Transform SaMD’s from a Cost Center to Revenue Center

We help you future-proof your DTx investments. So post all is said and done, you have a DTx asset that you can commercialize at scale by co-ownership of the DTx Solution. We work with you right from the start so you can focus on the key commercialization metrics that matter to you.

Learn About Value Creation

Building Digital Health Solutions
to 2X Adoption

We focus on improving Quality of Life(QOL) with behavior-led personalization and 2X patient engagement and retention with gamification-led human-centered design. We save clinicians’ time with an integrated clinician utility that provides a unified view of patients, real-time actionable insights, alerts, and notifications.

Learn How We Augment Outcomes
Building-Digital-Health-Solutions

Medical-grade SaMD Solutions Compliant to Global Standards

Our Digital Therapeutics Platform
puts the Patient at the Centre

We are Committed to Transforming the Lives of our Patients

Our hypertensive patients achieved significant
reduction in blood pressure levels

7.4 mmHg

Systolic BP reduced

3.7 mmHg

Diastolic BP reduced

Presented at
The American College of Cardiology’s 69th Annual Scientific Session & Expo

Our therapy is designed to reflect immediate
improvements in self-care behaviours

After one month in the programme, our patients experienced:

34%

Carbs Reduced

38%

Fats Reduced

55%

Fiber increased

We have show consistent outcomes with
Type 2 Diabetes patients year on year

website-partner-cycle-img-3

We ensure our patients experience long-lasting results

In the first 2 months, our diabetes patients
experienced a significant drop in blood glucose,
which was sustained over a period of 6 months

15 mg/dl

Fasting blood glucose

25 mg/dl

Post meal blood glucose

Presented at
80th Scientific Session of the American Diabetaes Association

Explore our Real World Outcomes
doctor-talk

Awards and Recognitions

Endorsed by the
ADA as a prescribable
digital therapeutic

Selected in
the NASSCOM
Emerge 50 2019 cohort

Part of
NASSCOM’s
League of 10 in 2019

Our collaborations

Improving Quality of Life with Integrated Care Interventions

quote

Easy to use !! Helpful and informative !! All required information in single app !!

– Chetan Sarda

quote

Very good it take care app n very good dietitian program.

– Sunil Gupta

quote

This is my feedback for the program on Sugar control which I attended and was very happy with. I was given advice by Sakshi my health adviser on a weekly basis who gave me lot of inputs on Diet, exercise and related issues and my Sugar levels became more stable and in the recommended range.
– Satinder M Bedi

quote

This has helped in better regulation of sugar and GERD. My HBA1C reading are better too. I would highly recommended others to enroll for this program and experience the benefit.- Amit Bansal

Read more